196 related articles for article (PubMed ID: 12028020)
1. Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology.
Gowans D; O'Sullivan A; Rollinson S; Roddam P; Groves M; Fegan C; Morgan G; Bowen D
Br J Haematol; 2002 Jun; 117(3):541-5. PubMed ID: 12028020
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the acetylcholinesterase locus at 7q22 associated with myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML).
Stephenson J; Czepulkowski B; Hirst W; Mufti GJ
Leuk Res; 1996 Mar; 20(3):235-41. PubMed ID: 8637218
[TBL] [Abstract][Full Text] [Related]
3. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease.
Verity DH; Wallace GR; Vaughan RW; Kondeatis E; Madanat W; Zureikat H; Fayyad F; Marr JE; Kanawati CA; Stanford MR
Tissue Antigens; 1999 Sep; 54(3):264-72. PubMed ID: 10519363
[TBL] [Abstract][Full Text] [Related]
4. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.
Koss K; Satsangi J; Fanning GC; Welsh KI; Jewell DP
Genes Immun; 2000 Feb; 1(3):185-90. PubMed ID: 11196710
[TBL] [Abstract][Full Text] [Related]
5. The frequency of HLA class I and II alleles in Turkish childhood acute leukaemia patients.
Ozdilli K; Oguz FS; Anak S; Kekik C; Carin M; Gedikoglu G
J Int Med Res; 2010; 38(5):1835-44. PubMed ID: 21309500
[TBL] [Abstract][Full Text] [Related]
6. Immunologic characteristics and prognosis of myelodysplastic syndrome new subtype: refractory anemia with excess blasts-II.
Wei J; Zhou XF; Zhao F; Zhou JF; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):111-6. PubMed ID: 19236759
[TBL] [Abstract][Full Text] [Related]
7. High frequency of human leukocyte antigen class II DRB1*1602 haplotype in Greek patients with myelodysplastic syndrome and of DRB1*1501 in the low-risk subgroup.
Kritikou-Griva E; Spyropoulou-Vlachou M; Tsagarakis NJ; Goumakou E; Vrani V; Galanopoulos A; Papadhimitriou SI; Androutsos G; Paterakis G; Stavropoulos-Giokas C
Hum Immunol; 2012 Mar; 73(3):278-81. PubMed ID: 22244918
[TBL] [Abstract][Full Text] [Related]
8. HLA class II allele and haplotype frequencies in Iranian patients with leukemia.
Khosravi F; Amirzargar A; Sarafnejad A; Nicknam MH; Alimoghadam K; Dianat S; Solgi G; Nikbin B
Iran J Allergy Asthma Immunol; 2007 Sep; 6(3):137-42. PubMed ID: 17893434
[TBL] [Abstract][Full Text] [Related]
9. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
10. Association and interaction of the TNF-alpha gene with other pro- and anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India.
Kumar R; Goswami R; Agarwal S; Israni N; Singh SK; Rani R
Tissue Antigens; 2007 Jun; 69(6):557-67. PubMed ID: 17498265
[TBL] [Abstract][Full Text] [Related]
11. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease.
Bouma G; Crusius JB; Oudkerk Pool M; Kolkman JJ; von Blomberg BM; Kostense PJ; Giphart MJ; Schreuder GM; Meuwissen SG; Peña AS
Scand J Immunol; 1996 Apr; 43(4):456-63. PubMed ID: 8668926
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic evolution following the transformation of myelodysplastic syndrome to acute myelogenous leukemia: implications on the overlap between the two diseases.
Ghaddar HM; Stass SA; Pierce S; Estey EH
Leukemia; 1994 Oct; 8(10):1649-53. PubMed ID: 7934160
[TBL] [Abstract][Full Text] [Related]
13. Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer.
Gamzatova Z; Villabona L; van der Zanden H; Haasnoot GW; Andersson E; Kiessling R; Seliger B; Kanter L; Dalianis T; Bergfeldt K; Masucci GV
Tissue Antigens; 2007 Sep; 70(3):205-13. PubMed ID: 17661908
[TBL] [Abstract][Full Text] [Related]
14. Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation.
Tien HF; Tang JH; Tsay W; Liu MC; Lee FY; Wang CH; Chen YC; Shen MC
Br J Haematol; 2001 Jan; 112(1):148-54. PubMed ID: 11167795
[TBL] [Abstract][Full Text] [Related]
15. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G--possible implications for human reproduction and autoimmune disease.
Hviid TV; Christiansen OB
Hum Immunol; 2005 Jun; 66(6):688-99. PubMed ID: 15993714
[TBL] [Abstract][Full Text] [Related]
16. Immunoprinting excludes many potential susceptibility genes as predisposing to early onset pauciarticular juvenile chronic arthritis except HLA class II and TNF.
Epplen C; Rumpf H; Albert E; Haas P; Truckenbrodt H; Epplen JT
Eur J Immunogenet; 1995 Aug; 22(4):311-22. PubMed ID: 7495783
[TBL] [Abstract][Full Text] [Related]
17. TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype.
McManus R; Wilson AG; Mansfield J; Weir DG; Duff GW; Kelleher D
Eur J Immunol; 1996 Sep; 26(9):2113-8. PubMed ID: 8814255
[TBL] [Abstract][Full Text] [Related]
18. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease.
Mullighan CG; Fanning GC; Chapel HM; Welsh KI
J Immunol; 1997 Dec; 159(12):6236-41. PubMed ID: 9550427
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes.
Zhang Z; Li X; Guo J; Xu F; He Q; Zhao Y; Yang Y; Gu S; Zhang Y; Wu L; Chang C
Eur J Haematol; 2013 May; 90(5):375-84. PubMed ID: 23331180
[TBL] [Abstract][Full Text] [Related]
20. Impact of immunogenetic polymorphisms in bone marrow failure syndromes.
Serio B; Selleri C; Maciejewski JP
Mini Rev Med Chem; 2011 Jun; 11(6):544-52. PubMed ID: 21561401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
